Financial Contrast: Rosetta Genomics (ROSG) and Its Peers

Financial Contrast: Rosetta Genomics (ROSG) and Its Peers


Rosetta Genomics is one of 186 public companies in the "Biotechnology & Medical Research" industry, but how does it contrast to its peers? We will compare Rosetta Genomics to similar companies based on the strength of its institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability. This is a breakdown of recent ratings and recommmendations for Rosetta Genomics and its peers, as provided by MarketBeat.com.



from Biotech News